VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Rickettsia DNA Vaccine encoding OmpB Protein boosted with Recombinant OmpB
Vaccine Information
  • Vaccine Name: Rickettsia DNA Vaccine encoding OmpB Protein boosted with Recombinant OmpB
  • Target Pathogen: Rickettsia spp
  • Target Disease: Spotted Fever, Typhus
  • Vaccine Ontology ID: VO_0011389
  • Type: DNA vaccine
  • Status: Research
  • ompB gene engineering:
    • Type: DNA vaccine construction
    • Description:
    • Detailed Gene Information: Click Here.
  • DNA vaccine plasmid:
    • DNA vaccine plasmid name:
    • DNA vaccine plasmid VO ID: VO_0005062
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Mouse Response

  • Host Strain: C3H/ HeN
  • Vaccination Protocol: Animals were immunized with only two doses of DNA (100 μg of recombinant plasmid and 100 μg of pIL-12) four weeks apart given intramuscularly in the tibialis anterior muscles. All mice that received DNA immunizations were also administered two booster immunizations of 100 μg each of the homologous purified recombinant protein. Control mice received either non-recombinant vector plus β-galactosidase-His recombinant protein (negative control) or a sublethal immunizing dose of R. conorii (positive
    control) (Díaz-Montero et al., 2001).
  • Challenge Protocol: Mice were challenged with 3 median lethal doses (LD50) of R. conorii. In a previous experiment, this dose was shown to kill 100% of naive mice. After challenge, animals were observed daily for morbidity and mortality (Díaz-Montero et al., 2001).
  • Efficacy: R. rickettsii OmpB contain B and T lymphocyte epitopes. Immunizations with each of two fragments from OmpB (rompB1550-2738 and rompB2459-4123) conferred protection against challenge with a lethal dose of R. conorii. Protection appeared to be better achieved among the groups that received both DNA and recombinant protein immunizations, although recombinant protein immunizations alone provided some protection (Díaz-Montero et al., 2001).
References
Díaz-Montero et al., 2001: Díaz-Montero CM, Feng HM, Crocquet-Valdes PA, Walker DH. Identification of protective components of two major outer membrane proteins of spotted fever group Rickettsiae. The American journal of tropical medicine and hygiene. 2001; 65(4); 371-378. [PubMed: 11693887].